TECH · 10-Q/A · 2026Q3 · Full report

Income Tax Rate Changes

BIO-TECHNE Corp · 2026-11-12 · Importance 18 · Surprise 14

The effective income tax rate was 18.4% for the quarter ended September 30, 2026, compared with 20.4% in the prior-year quarter, reflecting the mix of net income and timing of discrete items. The forecasted tax rate before discrete items declined to 23.4% from 26.5% in the prior-year forecast. Excluding discrete items, the Company expects its consolidated income tax rate for the remainder of fiscal 2027 to range from 23% to 27%.

Key facts

• Bio-Techne expects its consolidated income tax rate, excluding discrete items, to range from 23% to 27% for the remainder of fiscal 2027. source
• BIO-TECHNE's effective income tax rate was 18.4% in the first quarter of fiscal 2027, compared with 20.4% in the first quarter of fiscal 2026. source
• Bio-Techne’s effective tax rate was 18.4% for the quarter ended September 30, 2026, versus 20.4% in the prior-year quarter; the change was driven by net-income mix and timing of discrete items. source
• BIO-TECHNE recognized net benefits from discrete tax items of $1.8 million in the quarter ended September 30, 2026, compared with $3.6 million in the prior-year quarter. source
• BIO-TECHNE's share-based compensation excess tax benefit was $1.9 million in the quarter ended September 30, 2026, compared with $0.5 million in the quarter ended September 30, 2025. source
• Bio-Techne’s forecast tax rate before discrete items for the first fiscal quarter of 2026 was 23.4%, versus 26.5% in the prior-year forecast. source